Ampelopsin Induces DR5-Mediated Apoptotic Cell Death in EBV-Infected Cells through the p38 Pathway
- 15 July 2019
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 72 (3) , 489-494
Abstract
Ampelopsin (AMP) is a well-known flavonoid that exerts a number of biological and pharmacological effects including anticancer effects against several cancer cell lines. In this study, we investigated the anticancer activity of AMP against Epstein-Barr virus (EBV)-positive cells and its mechanism of action. Our results showed that AMP dose-dependently inhibited cell viability and induced apoptotic cell death in EBV-positive cells without cytotoxicity in EBV-negative cells. In particular, AMP induced caspase-8 dependent apoptosis via upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR5). Knockdown of DR5 by RNA interference blocked AMP-induced apoptosis. Furthermore, AMP dose-dependently activated p38 mitogen-activated protein kinases (MAPKs) in EBV-positive cells. Additionally, SB203580 (a p38-MAPK inhibitor) effectively inhibited apoptotic cell death. These results demonstrate that treatment with AMP induces the apoptosis of EBV-positive cells through upregulation of TRAIL/DR5 and activation of p38 signaling. Therefore, these results provide experimental information for developing AMP as a new therapeutic drug against EBV-positive cancer.Keywords
Funding Information
- the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare Affairs, Republic of Korea (HI15C2800)
This publication has 21 references indexed in Scilit:
- Flavonoid Ampelopsin Inhibits the Growth and Metastasis of Prostate Cancer In Vitro and in MicePLOS ONE, 2012
- Endoplasmic Reticulum Stress-Mediated Apoptosis of EBV-Transformed B Cells by Cross-Linking of CD70 Is Dependent upon Generation of Reactive Oxygen Species and Activation of p38 MAPK and JNK PathwayThe Journal of Immunology, 2010
- Recurrence‐free survival in prostate cancer is related to increased stromal TRAIL expressionCancer, 2010
- Electrolyte Imbalances in Pediatric Living Related Small Bowel TransplantationTransplantation, 2008
- Isolation and identification of metabolites from dihydromyricetinMagnetic Resonance in Chemistry, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Epstein–Barr virus: 40 years onNature Reviews Cancer, 2004
- Aids-related malignanciesNature Reviews Cancer, 2002
- Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumorJournal of Cancer Research and Clinical Oncology, 2002
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995